|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.9 USD | -0.94% |
|
+0.77% | +44.04% |
| 05-06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
| 05-06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
Select Medical reaffirmed earnings guidance for the year 2024. The company expects revenue to be in the range of $6.9 billion to $7.1 billion, fully diluted earnings per share to be in the range of $1.95 to $2.19.
| 1st Jan change | Capi. | |
|---|---|---|
| +44.04% | 4.45B | |
| +18.97% | 84.52B | |
| -27.31% | 72.21B | |
| +4.65% | 27.74B | |
| -7.60% | 17.97B | |
| -0.46% | 17.46B | |
| +4.44% | 15.82B | |
| +8.52% | 13.55B | |
| +6.59% | 13.31B | |
| +69.82% | 12.5B |
SELECT MEDICAL HOLDINGS CORPORATION 
